TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,720 | -66.3% | 2,000 | 0.0% | 0.01% | -62.5% |
| Q2 2023 | $49,680 | +65.2% | 2,000 | 0.0% | 0.02% | +45.5% |
| Q1 2023 | $30,080 | +154.1% | 2,000 | 0.0% | 0.01% | +83.3% |
| Q4 2022 | $11,840 | -1.3% | 2,000 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $12,000 | +33.3% | 2,000 | 0.0% | 0.01% | +20.0% |
| Q2 2022 | $9,000 | -52.6% | 2,000 | 0.0% | 0.01% | -44.4% |
| Q1 2022 | $19,000 | -50.0% | 2,000 | 0.0% | 0.01% | -52.6% |
| Q4 2021 | $38,000 | -43.3% | 2,000 | 0.0% | 0.02% | -50.0% |
| Q3 2021 | $67,000 | -4.3% | 2,000 | 0.0% | 0.04% | -2.6% |
| Q2 2021 | $70,000 | -27.1% | 2,000 | 0.0% | 0.04% | -38.1% |
| Q1 2021 | $96,000 | -7.7% | 2,000 | 0.0% | 0.06% | -18.2% |
| Q4 2020 | $104,000 | +395.2% | 2,000 | 0.0% | 0.08% | +250.0% |
| Q1 2020 | $21,000 | – | 2,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 5,229,619 | $74,261,000 | 3.55% |
| RA Capital Management | 2,472,344 | $35,107,000 | 2.69% |
| SENZAR ASSET MANAGEMENT, LLC | 475,918 | $6,758,000 | 2.13% |
| BRIDGER MANAGEMENT, LLC | 2,373,920 | $33,710,000 | 2.04% |
| Opaleye Management Inc. | 274,200 | $3,893,000 | 1.11% |
| Virtus ETF Advisers LLC | 89,920 | $1,277,000 | 1.11% |
| Eversept Partners, LP | 150,000 | $2,130,000 | 0.99% |
| Ghost Tree Capital, LLC | 300,000 | $4,260,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $710,000 | 0.42% |
| HIGHLAND CAPITAL MANAGEMENT LP | 464,391 | $6,595,000 | 0.34% |